Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for cN+ Breast Cancer
Status:
Recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
To explore the feasibility of target biopsy of carbon nanoparticles labelled lymph node after
neoadjuvant systemic therapy for cN+ breast cancer, and evaluate whether it can accurately
predict axillary lymph node status after neoadjuvant systemic therapy.
Phase:
N/A
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University